Response to comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes.
This study examined Response to comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes. Findings provide evidence relevant to clinical and research application in this area.
This study examined Response to comment on: GLP-1 receptor agonists and male sexual health: translating cardiometabolic benefits into erectile outcomes. Findings provide evidence relevant to clinical and research application in this area.
What the study was
- Study design
- Not specified
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- International journal of impotence research
Why it surfaced
Low-signal Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk entry (Not specified design); retained for topic coverage completeness.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.